作为饮食失调症临床严重程度指标的最低体重抑制:回顾性队列研究

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS
Rami Bou Khalil , Anthony Kassab , Sami Richa , Maude Seneque , Patrick Lefebvre , Ariane Sultan , Antoine Avignon , Laurent Maimoun , Eric Renard , Philippe Courtet , Sebastien Guillaume
{"title":"作为饮食失调症临床严重程度指标的最低体重抑制:回顾性队列研究","authors":"Rami Bou Khalil ,&nbsp;Anthony Kassab ,&nbsp;Sami Richa ,&nbsp;Maude Seneque ,&nbsp;Patrick Lefebvre ,&nbsp;Ariane Sultan ,&nbsp;Antoine Avignon ,&nbsp;Laurent Maimoun ,&nbsp;Eric Renard ,&nbsp;Philippe Courtet ,&nbsp;Sebastien Guillaume","doi":"10.1016/j.eatbeh.2024.101853","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>Weight suppression (WS) defines the difference between the highest weight in adulthood and the current weight. WS at lowest weight is the difference between the highest and the lowest ever weight. Weight rebound is the difference between the past lowest weight and current weight. The distinction in the capacities of WS, weight rebound, and WS at the lowest weight remains unclear regarding their efficacy in forecasting clinical endpoints. This study assessed the relationship between WS, WS at lowest weight and/or weight rebound and eating disorder (ED) clinical severity.</p></div><div><h3>Methods</h3><p>In this retrospective cohort study, adult participants were selected at the Outpatient Unit for multidisciplinary assessment of ED, Montpellier, France, between February 2012 and October 2014 and May 2017 and January 2020. ED clinical severity was evaluated using the Eating Disorder Examination Questionnaire (EDE-Q).</p></div><div><h3>Results</h3><p>The sample included 303 patients: 204 with anorexia nervosa (AN) and 99 with bulimia nervosa (BN). The EDE-Q total score was positively correlated with WS at lowest weight in patients with AN (Spearman's rho = 0.181, <em>p</em> = 0.015) and with BN (Spearman's rho = 0.377; <em>p</em> &lt; 0.001). It was also positively correlated with weight rebound (Spearman's rho = 0.319; <em>p</em> = 0.003) in patients with BN. In the multivariate analysis, EDE-Q total score was associated with WS at lowest weight only in patients with BN (β = 0.265; <em>p</em> = 0.03).</p></div><div><h3>Conclusion</h3><p>WS at lowest weight seems to be a good measure of ED clinical severity. More research is needed for better understanding WS at lowest weight in assessment and treatment of patients with ED.</p></div>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Weight suppression at lowest weight as an indicator of eating disorder clinical severity: A retrospective cohort study\",\"authors\":\"Rami Bou Khalil ,&nbsp;Anthony Kassab ,&nbsp;Sami Richa ,&nbsp;Maude Seneque ,&nbsp;Patrick Lefebvre ,&nbsp;Ariane Sultan ,&nbsp;Antoine Avignon ,&nbsp;Laurent Maimoun ,&nbsp;Eric Renard ,&nbsp;Philippe Courtet ,&nbsp;Sebastien Guillaume\",\"doi\":\"10.1016/j.eatbeh.2024.101853\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><p>Weight suppression (WS) defines the difference between the highest weight in adulthood and the current weight. WS at lowest weight is the difference between the highest and the lowest ever weight. Weight rebound is the difference between the past lowest weight and current weight. The distinction in the capacities of WS, weight rebound, and WS at the lowest weight remains unclear regarding their efficacy in forecasting clinical endpoints. This study assessed the relationship between WS, WS at lowest weight and/or weight rebound and eating disorder (ED) clinical severity.</p></div><div><h3>Methods</h3><p>In this retrospective cohort study, adult participants were selected at the Outpatient Unit for multidisciplinary assessment of ED, Montpellier, France, between February 2012 and October 2014 and May 2017 and January 2020. ED clinical severity was evaluated using the Eating Disorder Examination Questionnaire (EDE-Q).</p></div><div><h3>Results</h3><p>The sample included 303 patients: 204 with anorexia nervosa (AN) and 99 with bulimia nervosa (BN). The EDE-Q total score was positively correlated with WS at lowest weight in patients with AN (Spearman's rho = 0.181, <em>p</em> = 0.015) and with BN (Spearman's rho = 0.377; <em>p</em> &lt; 0.001). It was also positively correlated with weight rebound (Spearman's rho = 0.319; <em>p</em> = 0.003) in patients with BN. In the multivariate analysis, EDE-Q total score was associated with WS at lowest weight only in patients with BN (β = 0.265; <em>p</em> = 0.03).</p></div><div><h3>Conclusion</h3><p>WS at lowest weight seems to be a good measure of ED clinical severity. More research is needed for better understanding WS at lowest weight in assessment and treatment of patients with ED.</p></div>\",\"PeriodicalId\":2,\"journal\":{\"name\":\"ACS Applied Bio Materials\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.6000,\"publicationDate\":\"2024-02-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Applied Bio Materials\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1471015324000126\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MATERIALS SCIENCE, BIOMATERIALS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1471015324000126","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

摘要

目标体重抑制(WS)是指成年后最高体重与当前体重之间的差值。最低体重时的体重抑制是指最高体重与最低体重之间的差值。体重反弹是指过去最低体重与当前体重之间的差值。关于 WS、体重反弹和最低体重 WS 在预测临床终点方面的功效,其能力的区别仍不明确。本研究评估了WS、最低体重时的WS和/或体重反弹与进食障碍(ED)临床严重程度之间的关系。方法在这项回顾性队列研究中,选取了2012年2月至2014年10月以及2017年5月至2020年1月期间在法国蒙彼利埃ED多学科评估门诊部就诊的成年参与者。研究使用饮食失调检查问卷(EDE-Q)对ED临床严重程度进行评估:结果样本包括303名患者:204名神经性厌食症(AN)患者和99名神经性贪食症(BN)患者。EDE-Q 总分与 AN 患者最低体重时的 WS 值呈正相关(Spearman's rho = 0.181,p = 0.015),与 BN 患者最低体重时的 WS 值呈正相关(Spearman's rho = 0.377;p < 0.001)。在 BN 患者中,它还与体重反弹呈正相关(Spearman's rho = 0.319;p = 0.003)。在多变量分析中,只有 BN 患者的 EDE-Q 总分与最低体重时的 WS 相关(β = 0.265;p = 0.03)。结论最低体重WS似乎是衡量ED临床严重程度的一个很好的指标,在对ED患者进行评估和治疗时,需要进行更多的研究以更好地了解最低体重WS。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Weight suppression at lowest weight as an indicator of eating disorder clinical severity: A retrospective cohort study

Objectives

Weight suppression (WS) defines the difference between the highest weight in adulthood and the current weight. WS at lowest weight is the difference between the highest and the lowest ever weight. Weight rebound is the difference between the past lowest weight and current weight. The distinction in the capacities of WS, weight rebound, and WS at the lowest weight remains unclear regarding their efficacy in forecasting clinical endpoints. This study assessed the relationship between WS, WS at lowest weight and/or weight rebound and eating disorder (ED) clinical severity.

Methods

In this retrospective cohort study, adult participants were selected at the Outpatient Unit for multidisciplinary assessment of ED, Montpellier, France, between February 2012 and October 2014 and May 2017 and January 2020. ED clinical severity was evaluated using the Eating Disorder Examination Questionnaire (EDE-Q).

Results

The sample included 303 patients: 204 with anorexia nervosa (AN) and 99 with bulimia nervosa (BN). The EDE-Q total score was positively correlated with WS at lowest weight in patients with AN (Spearman's rho = 0.181, p = 0.015) and with BN (Spearman's rho = 0.377; p < 0.001). It was also positively correlated with weight rebound (Spearman's rho = 0.319; p = 0.003) in patients with BN. In the multivariate analysis, EDE-Q total score was associated with WS at lowest weight only in patients with BN (β = 0.265; p = 0.03).

Conclusion

WS at lowest weight seems to be a good measure of ED clinical severity. More research is needed for better understanding WS at lowest weight in assessment and treatment of patients with ED.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信